Intuitive Surgical's stock surged 5.10% intraday on Wednesday, driven by the company's impressive first-quarter 2026 financial results that exceeded analyst expectations.
The robotic surgery leader reported revenue of $2.77 billion, beating estimates of $2.62 billion, and adjusted earnings of $2.50 per share, surpassing the consensus forecast of $2.10 per share. The company also raised its full-year guidance for Da Vinci procedure growth to 13.5%–15.5%, up from the previous range of 13%–15%.
Strong adoption of its Da Vinci 5, SP, and Ion systems, along with solid procedure growth in key markets, contributed to the upbeat results. The improved outlook and earnings beat bolstered investor confidence, fueling the significant stock price appreciation during the trading session.
Comments